The Zhang Lab researches the noncoding genome of cancer and has a long-term goal of discovering novel therapeutic opportunities. We apply omics analysis and high-throughput screening to generate hypotheses that we test using CRISPR-mediated genome/epigenome editing technologies.

Xiaoyang-Zhang.jpg

Xiaoyang Zhang, PhD
Principal Investigator
xiaoyang.zhang@hci.utah.edu

Cancer Center Bio